Quantum BioPharma Announces Q3 Results: Crypto Asset Portfolio Profits Reach $572,000
Jinse Finance reported that Quantum BioPharma (NASDAQ: QNTM) today announced its financial results for the third quarter of 2025, showing a significant improvement in the company's financial position. Shareholders' equity increased by 275% quarter-on-quarter, total liabilities decreased by 50%, and the debt-to-equity ratio dropped by 87%. The company's digital asset portfolio (mainly bitcoin) has realized a profit of $572,000, with the total value of digital assets rising from $800,000 at the end of 2024 to the current $5.2 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
CN Rail Downgraded to Market Perform at Raymond James
ANI Pharmaceuticals Launches Generic Cymbalta
Under 1,000 Shiba Inu (SHIB) Users Actually Withdraw Tokens From Exchanges
Lexeo Therapeutics to Host Investor Event on Clinical Endpoints in PKP2-ACM
Crypto prices
More
